President Donald Trump's proposed tariffs could raise the cost of some cancer treatments by as much as $10,000, while also raising prices for cheaper everyday drugs, a new analysis has found.

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

The global quest to prevent childhood cancer deaths has a long history. For decades, efforts have centred on driving innovation to produce more effective therapies, improve understanding in how and ...

A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Oncogenic proteins are essential for the development and spread of tumors, making cancer a significant worldwide health ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Based on the feedback received, this document may change. Learn about the consultation. Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible ...

A urine drug test can quickly detect both illegal and prescription drugs in a person’s system. Doctors, sports officials, and many employers require these tests. Signs of drug use can remain in ...

Thousands of women whose mothers took a widely prescribed drug in pregnancy face more than double the normal risk of breast cancer. A study of 5,000 women found that those over 40 whose mothers ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt ... its global presence to accelerate patient access to the drug. The deal also includes a contingent value right tied to ...

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and oncology company ... based company’s drug portfolio.